BSX Activators
BSX activators are a suite of chemical compounds that enhance the activity of BSX through specific and varied signaling pathways. Forskolin and IBMX both function to raise intracellular cAMP levels, leading to the activation of PKA. Activated PKA can then phosphorylate proteins that are regulatory partners of BSX, thereby increasing BSX's transcriptional activity. PMA, through activation of PKC, and sphingosine-1-phosphate, via G-protein-coupled receptor signaling, trigger downstream kinase cascades that ultimately enhance the activity of BSX by modulating the phosphorylation state of BSX or its associated proteins. Thapsigargin and A23187 further contribute to the activation of BSX by increasing intracellular calcium, a crucial secondary messenger that activates calcium-dependent kinases, which in turn can influence BSX's activity through phosphorylation mechanisms.
Epigallocatechin gallate (EGCG) and the PI3K inhibitors LY294002 and Wortmannin enhance BSX activity by inhibiting kinase pathways that might otherwise phosphorylate and inhibit proteins that regulate BSX function, thereby leading to an increase in BSX's transcriptional regulation capabilities. Additionally, U0126 and SB203580, which inhibit MEK1/2 and p38 MAPK respectively, may tilt the balance of intracellular signaling in favor of pathways that activate BSX, facilitating a more robust transcriptional response by BSX. Overall, these BSX activators work through diverse, yet interconnected biochemical pathways, ensuring the enhancement of BSX's functional role without necessitating changes in its expression levels.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cyclic AMP (cAMP) levels, which in turn activates PKA. PKA phosphorylation can enhance BSX activity by phosphorylating regulatory proteins that interact with BSX, leading to its functional activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX inhibits phosphodiesterases, preventing cAMP degradation, thereby sustaining the activation of PKA. Sustained PKA activity enhances BSX activity through phosphorylation of associated regulatory proteins. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate substrates that modulate BSX activity, thereby enhancing its functional role in transcriptional regulation. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which can signal through G-proteins to activate downstream kinases that phosphorylate proteins influencing BSX activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in intracellular calcium levels. Elevated calcium can activate calcium-dependent kinases and phosphatases, which may enhance BSX activity through direct or indirect effects. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several protein kinases, potentially reducing inhibitory phosphorylation on proteins interacting with BSX, thereby enhancing BSX transcriptional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, which may lead to a decrease in AKT phosphorylation and activity. This could enhance BSX activity by reducing negative feedback on pathways that BSX is involved in. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium levels which activates calcium-dependent signaling pathways, potentially enhancing BSX activity through these pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which may enhance BSX activity by alleviating p38 MAPK-mediated inhibitory effects on proteins that regulate BSX function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor, which can lead to reduced AKT activity and enhance BSX function by minimizing the inhibitory effects of AKT on BSX activation pathways. | ||||||